Crinetics Pharmaceuticals Cash Flow Statement (2017-2025) | CRNX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-22.89M	-26.07M	-27.78M	-30.81M	-33.63M	-42.33M	-41.95M	-45.65M	-45.94M	-50.89M	-56.41M	-55.94M	-66.21M	-74.04M	-76.83M	-80.59M	-96.57M	-115.66M	-130.09M	-122.64M
Share-based Compensation (Quarter)	3.41M	4.23M	4.55M	5.16M	5.75M	7.13M	7.43M	7.95M	8.10M	10.18M	11.05M	11.62M	13.45M	18.94M	18.15M	18.84M	20.48M	26.12M	22.70M	21.72M
Gains from Investment Securities (Quarter)	0.10M	0.01M	0.01M	0.01M	1.65M	8.52M	8.90M	-5.60M		12.42M	12.46M	-0.71M	14.46M	14.14M	5.00M	0.05M	4.10M	14.99M		0.04M
Non-cash Items (Quarter)	0.00M	0.00M	44.80M	80.91M	43.37M	3.41M	3.76M	4,122.61M	14.26M	22.27M	144.67M	5.26M	5.38M	288.96M	6.15M	6.48M	136.42M	7.45M
Cash from Operations (Quarter)	-20.07M	-19.95M	-25.67M	-22.90M	-13.54M	-27.98M	-38.48M	-35.21M	-40.72M	-45.73M	-41.34M	-40.81M	-52.86M	-47.64M	-62.82M	-66.87M	-88.45M	-85.85M	-110.72M	-92.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.08M	-0.09M	-0.07M	-0.19M	-0.32M	-0.20M	0.13M	0.35M	0.53M	0.91M	1.25M	-1.48M	3.85M	3.41M	-4.97M	12.65M	4.38M	4.71M	3.60M	2.73M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.22M	0.23M	0.23M	0.23M	0.24M	0.21M	0.25M	0.28M	0.28M	0.28M	0.27M	0.26M	0.47M	0.75M	0.77M	0.79M	0.93M	0.96M	1.01M	0.99M
Change in Working Capital
Change in Accured Expenses (Quarter)	-0.27M	2.17M	0.49M	3.90M	1.53M	6.71M	-1.33M	4.08M	-1.34M	7.42M	4.38M	1.90M	1.31M	5.21M	0.69M	6.12M	-1.36M	12.52M	6.65M	11.18M
Investing Activities
Capital Expenditures (Quarter)	0.02M	-0.02M	0.42M	0.02M		0.08M	-0.02M	1.60M	0.02M	0.02M	3.71M	0.94M	0.17M	2.12M	-2.23M	0.12M	0.26M	-0.18M	-0.03M	5.71M
Change in Acquisitions & Divestments (Quarter)	35.15M	20.00M	13.96M	0.24M	11.72M	18.90M	56.19M	70.69M	71.44M	91.17M	87.84M	86.68M	101.38M	139.30M	151.15M	183.97M	306.48M	224.03M	382.37M	271.21M
Cash from Investing Activities (Quarter)	32.50M	19.84M	-7.03M	-101.80M	-43.38M	-174.27M	6.82M	36.85M	48.76M	31.44M	-193.30M	-87.31M	0.31M	-53.64M	20.60M	-542.09M	-85.96M	37.95M	164.81M	57.11M
Financing Activities
Other financing activities (Quarter)												-0.43M	4.33M			-0.97M
Change in Capital Stock
Shares Issued (Quarter)	0.06M	-0.04M	-70.16M	0.74M	1.78M	115.47M	-0.01M	-112.52M	0.48M	1.12M		368.44M	383.21M	2.03M	48.30M	952.15M		2.88M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	0.06M	73.30M	15.46M	163.86M	1.78M	118.99M	1.08M	0.12M	0.48M	12.66M	337.88M	40.22M	393.57M	7.52M	57.33M	556.24M	4.44M	7.05M	3.08M	26.04M
Change in Cash (Quarter)	12.49M	73.19M	-17.23M	39.16M	-55.15M	-83.25M	-30.58M	1.76M	8.52M	-1.64M	103.24M	-87.90M	341.03M	-93.76M	15.11M	-52.72M	-169.98M	-40.84M	57.17M	-9.76M
Free Cash Flow (Quarter)	-20.09M	-19.93M	-26.09M	-22.92M	-13.54M	-28.06M	-38.46M	-36.80M	-40.73M	-45.76M	-45.05M	-41.74M	-53.02M	-49.76M	-60.60M	-66.99M	-88.72M	-85.67M	-110.69M	-98.61M
Net Cash Flow (Quarter)	12.49M	73.19M	-17.23M	39.16M	-55.15M	-83.25M	-30.58M	1.76M	8.52M	-1.64M	103.24M	-87.90M	341.03M	-93.76M	15.11M	-52.72M	-169.98M	-40.84M	57.17M	-9.76M

Research Tools

Crinetics Pharmaceuticals Cash Flow Statement (2017-2025) | CRNX

Create an account

Sign In

Reset Password